Vikram Talwar, MD
Orthopaedic Surgery · Danville, CANPI 1164499901
Payments from drug & device makers
Across 77 payments — averaging $491.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innovasis Inc$20K
- Precision Spine, Inc.$9K
- Globus Medical$3K
- Alphatec Spine, Inc$3K
- Cerapedics Inc.$2K
- Si-bone, Inc.$957
- plus $1K from 8 others
What the payments were for
- Consulting fees$15,29840%
- Speaking & faculty fees$4,88513%
- Travel & lodging$14,97240%
- Food & beverage$2,7127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innovasis Inc | 16 | $19,874 |
| Precision Spine, Inc. | 4 | $8,531 |
| Globus Medical | 11 | $3,008 |
| Alphatec Spine, Inc | 23 | $2,916 |
| Cerapedics Inc. | 1 | $1,500 |
| Si-bone, Inc. | 9 | $957 |
| Seaspine Orthopedics Corporation | 4 | $457 |
| Centinel Spine, LLC | 2 | $217 |
| Orthofix Medical, Inc. | 2 | $144 |
| Nevro Corp. | 1 | $127 |
| Saluda Medical Americas, Inc. | 1 | $70 |
| Terumo BCT, Inc. | 1 | $43 |
| Array Biopharma Inc | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALIF$8,326
- i-FACTOR Putty$1,500
- Excelsius Robotics System$1,346
- Excelsius - GPS$1,218
- Other - Miscellaneous$1,138
- IFUSE IMPLANT SYSTEM$452
- Mariner$400
- EXCELSIUS$271
- Vault C$205
- Vu aPOD Prime NanoMetalene$200
- PRODISC C VIVO$148
- Senza Spinal Cord Stimulation System$127
- M6-C$108
How this compares
$37,866 in reported general payments places this provider in the 85th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $893 |
| Oxycodone Hcl | 17 | $553 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $425 |
| Gabapentin | 16 | $136 |
| Nortriptyline Hcl | 24 | $123 |
| Tramadol Hcl | 13 | $101 |
| Cyclobenzaprine Hcl | 18 | $48 |
| Meloxicam | 21 | $46 |
| Zolpidem Tartrate | 17 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Danville
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.